<DOC>
	<DOCNO>NCT02955368</DOCNO>
	<brief_summary>The purpose study determine superiority DP-R212 comparing monotherapy patient hypertension primary hypercholesterolemia .</brief_summary>
	<brief_title>Clinical Trial Evaluate Efficacy Safety DP-R212</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Both man woman 19 year old Hypertension patient hypercholesterolemia sSBP difference ≥20mmHg sDBP difference ≥10mmHg A history cardiovascular disease rhabdomyolysis , myopathy Hypertension hypercholesterolemia due secondary cause Uncontrolled diabetes Evidence hepatic renal disease</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>DP-R212</keyword>
</DOC>